• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
FRE

FIREBRICK PHARMA LIMITED - Charts / Financials

0.00% ! 6.5¢
Market Cap $16.27M  !

Firebrick Pharma (ASX:FRE) is an Australian pharmaceutical developer focused on... Firebrick Pharma (ASX:FRE) is an Australian pharmaceutical developer focused on developing and commercializing novel formulations and uses of povidone-iodine. After more than 10 years of R&D including multiple human clinical trials, Firebrick's first product, Nasodine® Nasal Spray, is now available for sale in USA and Singapore.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

refresh Created with Sketch. REFRESH
Day
Open 6.8¢   Day High 6.8¢   Day Low 6.5¢
Daily Volume 17000
Bids   Sellers
Number Price Volume   Number Price Volume
1 6.5¢ 24891   2 6.8¢ 79497

Directors & Senior Management

Dr. Peter Molloy Chief Executive Officer, Founder, Executive Chairman of the Board
Mr. Stephen Francis Goodall Founder, Chief Operating Officer, Executive Director
Mr. Kavi Bekarma Chief Financial Officer
Mr. Stephen Buckley Company Secretary
Mr. Peter Kash Non-Executive Director
Mr. Rick L. Legleiter Non-Executive Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
6.5¢
Change
0.000(0.00%)
Mkt cap ! $16.27M
Open High Low Value Volume
6.8¢ 6.8¢ 6.5¢ $1.129K 17K

Buyers (Bids)

No. Vol. Price($)
1 24891 6.5¢
 

Sellers (Offers)

Price($) Vol. No.
6.8¢ 79497 2
View Market Depth
Last trade - 12.22pm 19/09/2025 (20 minute delay) ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.